Literature DB >> 6687503

Unchanged biochemical indices of bone turnover despite fluctuations in 1,25-dihydroxyvitamin D during the menstrual cycle.

L Tjellesen, C Christiansen, L Hummer, N E Larsen.   

Abstract

To examine the effect of endogenous oestrogens on calcium metabolism during the menstrual cycle, fasting blood and urinary samples were obtained every day throughout the menstrual cycle in 5 young women. Bone turnover was estimated by serum alkaline phosphatase and fasting urinary excretions of hydroxyproline and calcium. Serum levels of oestradiol (E2), oestrone (E1), and androstenedione (A) showed the well known cyclic fluctuations, the serum 1,25-dihydroxyvitamin D (1,25(OH)2D) nearly doubled from the early follicular phase to the time of ovulation, although 25-hydroxyvitamin D (25OHD) and 24,25-dihydroxyvitamin D (24,25(OH)2D) were almost unchanged. No correlation between the rise in the serum 1,25(OH)2D level and the measured parameters of calcium metabolism was observed. In view of these findings, the 1,25(OH)2D3 serum concentration measured in women with functioning ovaries can only be interpreted in the context of the menstrual cycle. The published normal range in women for the metabolite may also require reinterpretation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687503     DOI: 10.1530/acta.0.1020476

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  9 in total

1.  Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.

Authors:  P L Selby; M Peacock
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-22

2.  The effect of endogenous estrogen fluctuation on metabolism of 25-hydroxyvitamin D.

Authors:  J R Buchanan; R Santen; S Cauffman; A Cavaliere; R B Greer; L M Demers
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

Review 3.  Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.

Authors:  J A Balfour; R C Heel
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

4.  Urinary biochemical markers for bone resorption during the menstrual cycle.

Authors:  I Gorai; O Chaki; M Nakayama; H Minaguchi
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333

5.  Dietary vitamin D3 supplements reduce demyelination in the cuprizone model.

Authors:  Stig Wergeland; Øivind Torkildsen; Kjell-Morten Myhr; Lage Aksnes; Sverre Jarl Mørk; Lars Bø
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

6.  Serum 25-hydroxyvitamin D levels throughout pregnancy: a longitudinal study in healthy and preeclamptic pregnant women.

Authors:  Yessica Agudelo-Zapata; Luis Miguel Maldonado-Acosta; Héctor Fabio Sandoval-Alzate; Natalia Elvira Poveda; María Fernanda Garcés; Jonathan Alexander Cortés-Vásquez; Andrés Felipe Linares-Vaca; Carlos Alejandro Mancera-Rodríguez; Shahar Alexandra Perea-Ariza; Karen Yuliana Ramírez-Iriarte; Camilo Andrés Castro-Saldarriaga; Juan Manuel Arteaga-Diaz; Roberto Franco-Vega; Edith Ángel-Müller; Arturo José Parada-Baños; Jorge E Caminos
Journal:  Endocr Connect       Date:  2018-04-17       Impact factor: 3.335

7.  Vitamin D metabolites across the menstrual cycle: a systematic review.

Authors:  Anita Subramanian; Alison D Gernand
Journal:  BMC Womens Health       Date:  2019-01-28       Impact factor: 2.809

Review 8.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

9.  Vitamin D and Reproductive Hormones Across the Menstrual Cycle.

Authors:  Q E Harmon; K Kissell; A M Z Jukic; K Kim; L Sjaarda; N J Perkins; D M Umbach; E F Schisterman; D D Baird; S L Mumford
Journal:  Hum Reprod       Date:  2020-02-29       Impact factor: 6.918

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.